Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1,164.60%171.39M | 308.57%255.08M | -74.84%178.79M | 22.84%877.6M | -41.32%120.54M | -114.61%-16.1M | -67.98%62.43M | 248.70%710.73M | 19.92%714.45M | -24.05%205.44M |
| Net income from continuing operations | 103.66%23.12M | 562.24%160.75M | 29.05%62.56M | -1,606.81%-626.65M | 92.06%-9.33M | -1,714.87%-631.03M | -137.86%-34.78M | -52.42%48.48M | -85.50%41.59M | -166.53%-117.4M |
| Operating gains losses | 11,581.81%107.93M | 129.42%20.36M | 526.28%50.12M | -343.26%-63.95M | -220.39%-3.28M | 89.20%-940K | -1,006.57%-69.18M | 465.27%8M | -571.04%-14.43M | 37.54%2.72M |
| Depreciation and amortization | 18.87%104.67M | 8.10%102.71M | -0.98%89.56M | -8.69%367.41M | -13.84%93.9M | -13.31%88.05M | 0.37%95.01M | -6.91%90.45M | 4.82%402.37M | -16.49%108.98M |
| Asset impairment expenditure | --0 | --0 | --5.12M | 156.40%877.01M | --0 | 489.47%661.16M | 4,318.67%215.85M | --0 | 2,885.54%342.05M | 3,849.04%208.55M |
| Remuneration paid in stock | 1.13%5.09M | 73.57%8.02M | 20.29%5.87M | 33.94%24.34M | 89.68%9.81M | 83.08%5.03M | 35.93%4.62M | -28.82%4.88M | -26.35%18.17M | -21.48%5.17M |
| Deferred tax | 356.74%31.1M | 17.23%-29.1M | -137.77%-9.03M | 180.84%7.39M | 316.58%30.74M | -246.40%-12.11M | -953.49%-35.16M | 20,167.80%23.92M | -133.29%-9.14M | 70.68%-14.19M |
| Other non cashItems | 1,883.51%156.78M | 97.25%38.18M | -92.44%39.8M | 838.55%574.84M | -3,895.72%-1.06B | -34.46%7.9M | 43.67%19.36M | 16,681.03%526.25M | 917.41%61.25M | 1,218.33%27.88M |
| Change In working capital | 93.66%-8.51M | 65.61%-45.84M | -845.30%-65.21M | -121.94%-282.78M | -47.95%-24.08M | -61.39%-134.16M | -3,505.36%-133.29M | 144.61%8.75M | -9.77%-127.42M | -2,945.45%-16.28M |
| -Change in receivables | 75.38%-18.56M | 28.37%-38.86M | -169.75%-49.94M | 29.09%-74.61M | 146.25%12.48M | -158.99%-75.38M | -238.31%-54.25M | 44.05%-18.51M | -54.76%-105.21M | 11.56%-26.98M |
| -Change in inventory | 44.70%-60.88M | 43.43%-29.86M | -2,425.26%-44.46M | -267.94%-185.75M | -876.25%-68.29M | -160.55%-110.09M | -610.78%-52.79M | 108.44%1.91M | -0.42%-50.48M | 133.78%8.8M |
| -Change in payables and accrued expense | 147.54%126.99M | 187.18%22.89M | 15.15%29.19M | -179.28%-22.42M | -3,910.62%-72.82M | 535.69%51.3M | -1,411.89%-26.25M | -29.86%25.35M | 1,196.06%28.28M | -96.65%1.91M |
| -Change in other working capital | --70.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1,164.60%171.39M | 308.57%255.08M | -74.84%178.79M | 22.84%877.6M | -41.32%120.54M | -114.61%-16.1M | -67.98%62.43M | 248.70%710.73M | 19.92%714.45M | -24.05%205.44M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -69.86%-277.46M | -118.10%-236.44M | 18.57%-195.08M | 9.70%-763.3M | 12.33%-251.97M | 30.48%-163.35M | 43.50%-108.41M | -82.76%-239.58M | -117.43%-845.34M | -138.27%-287.42M |
| Capital expenditure reported | ---- | ---- | ---- | 69.88%-16.86M | ---- | ---- | ---- | ---- | -112.76%-55.98M | ---- |
| Net PPE purchase and sale | ---- | ---- | ---- | 136.78%7.5M | --0 | --7.5M | ---- | ---- | 57.74%-20.39M | ---20.39M |
| Net business purchase and sale | --0 | -104.79%-4.8M | ---- | 190.39%91.21M | --0 | ---9.09M | 163.38%100.3M | --0 | 24.23%31.41M | ---6.67M |
| Net investment purchase and sale | -127.97%-16.21M | 31.94%16.37M | ---1.81M | 295.34%65.01M | -924.67%-5.36M | 6,694.20%57.96M | 174.02%12.41M | --0 | -330.17%-33.28M | ---523K |
| Net other investing changes | -23.10%-261.25M | -12.16%-248.01M | 19.33%-193.27M | -18.65%-910.17M | -16.38%-237.25M | 9.33%-212.22M | -3.71%-221.12M | -112.75%-239.58M | -131.22%-767.1M | -116.13%-203.86M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -69.86%-277.46M | -118.10%-236.44M | 18.57%-195.08M | 9.70%-763.3M | 12.33%-251.97M | 30.48%-163.35M | 43.50%-108.41M | -82.76%-239.58M | -117.43%-845.34M | -138.27%-287.42M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 24.27%176.07M | 19.87%-41.89M | 104.00%8.27M | 64.12%-69.07M | -41.39%48.15M | 339.00%141.68M | 68.80%-52.28M | -332.09%-206.62M | 8.89%-192.51M | 271.07%82.16M |
| Net issuance payments of debt | 0.54%195.27M | -99.23%-9.28M | 130.90%47.53M | 84.05%240.21M | 40.97%204.48M | 4,337.90%194.22M | 5.55%-4.66M | -2,963.83%-153.84M | 594.02%130.51M | 1,777.81%145.05M |
| Net common stock issuance | ---9.85M | ---- | ---- | --10.07M | --10.07M | --0 | ---- | ---- | --0 | ---- |
| Cash dividends paid | 43.79%-25.92M | 43.41%-25.96M | 44.44%-25.55M | 1.12%-184.63M | -0.05%-46.66M | -1.62%-46.11M | 11.33%-45.87M | -7.01%-45.99M | -9.43%-186.72M | -8.62%-46.64M |
| Proceeds from stock option exercised by employees | 5,026.36%29.17M | 190.05%3.94M | 105.06%2.23M | -75.71%3.12M | -76.52%108K | -91.23%569K | -60.83%1.36M | -55.48%1.09M | -9.96%12.85M | -64.89%460K |
| Interest paid (cash flow from financing activities) | -626.98%-7.82M | -5.32%-1.15M | 2.37%-3.49M | -154.21%-11.65M | -427.61%-5.9M | 19.96%-1.08M | 2.50%-1.09M | -257.19%-3.58M | -2.83%-4.58M | 20.47%-1.12M |
| Net other financing activities | 19.18%-4.79M | -367.97%-9.44M | -188.91%-12.45M | 12.71%-126.19M | -630.73%-113.94M | 59.04%-5.92M | 98.22%-2.02M | -240.63%-4.31M | -501.06%-144.57M | -526.15%-15.59M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 24.27%176.07M | 19.87%-41.89M | 104.00%8.27M | 64.12%-69.07M | -41.39%48.15M | 339.00%141.68M | 68.80%-52.28M | -332.09%-206.62M | 8.89%-192.51M | 271.07%82.16M |
| Net cash flow | ||||||||||
| Beginning cash position | -33.92%308.49M | -41.86%330.12M | 9.80%336.97M | -52.93%306.9M | 39.26%431.11M | -7.78%466.84M | -15.72%567.81M | -52.93%306.9M | -3.13%651.95M | -43.66%309.57M |
| Current changes in cash | 285.38%70M | 76.33%-23.25M | -103.03%-8.02M | 113.99%45.23M | -46,621.79%-83.27M | 79.48%-37.76M | 40.26%-98.26M | 961.71%264.53M | -7,475.45%-323.4M | -99.82%179K |
| Effect of exchange rate changes | -653.39%-11.27M | 159.68%1.62M | 132.58%1.18M | 30.02%-15.16M | -280.93%-10.87M | 116.14%2.04M | 11.44%-2.72M | -15.57%-3.61M | -29.02%-21.66M | -538.92%-2.85M |
| End cash Position | -14.82%367.23M | -33.92%308.49M | -41.86%330.12M | 9.80%336.97M | 9.80%336.97M | 39.26%431.11M | -7.78%466.84M | -15.72%567.81M | -52.93%306.9M | -52.93%306.9M |
| Free cash from | 1,164.60%171.39M | 308.57%255.08M | -74.84%178.79M | 34.89%860.74M | -19.67%103.68M | -114.61%-16.1M | -67.98%62.43M | 249.57%710.73M | 22.42%638.09M | -47.14%129.08M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.